Higher-Level Pathway Objectives of Epigenetic Therapy: A Solution to the p53 Problem in Cancer

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Volumn 37, Issue , 2017, Pages 812-824

  Velcheti, Vamsidhar ^a   Radivoyevitch, Tomas ^a   Saunthararajah, Yogen ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA (CYTOSINE 5) METHYLTRANSFERASE 1; DNMT1 PROTEIN, HUMAN; MYC PROTEIN; MYC PROTEIN, HUMAN; PROTEIN P53; TP53 PROTEIN, HUMAN;

ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SELF-RENEWAL; GENETIC EPIGENESIS; GENETICS; HUMAN; MUTATION; NEOPLASM; PATHOLOGY;

APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SELF RENEWAL; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; EPIGENESIS, GENETIC; HUMANS; MUTATION; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 85028928385     PISSN: None     EISSN: 15488756     Source Type: Journal    
DOI: 10.14694/EDBK_174175     Document Type: Review

References (0)